Tribune Secures €37M to Revolutionize Fibrosis Treatment
Startup aims for clinical trial of lead candidate in IPF while advancing additional programs targeting CCN proteins. Scandinavian biotech Tribune … Continue reading "Tribune raises â¬37m to advance fibrosis-targeting therapeutics"...
